It is further confirmed that lncRNA-NEAT1 inhibits cellular senescence in HCC through KIF11-dependent CDKN2A inhibition, and targeted regulation of lncRNA-NEAT1or KIF11-induced hepatocyte senescence is a potential therapy to inhibit the development of HCC. The gene discussed is CDKN2A; the disease is hepatocellular carcinoma.